Showing results (1221-1230 of 4,506) with videos related to

Sort By:
Pageof 451
Advances in Therapy|October 27, 2021
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019Nancy Reau, Mark S Sulkowski, Emmanuel Thomas, et al.
Advances in Therapy|October 25, 2021
Cost-Effectiveness of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma in the United StatesYe Peng, Zhihua She, Liubao Peng, et al.
Advances in Therapy|October 1, 2021
Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in BavariaKonstantin Drexler, Hans Drexler, Edward K Geissler, et al.
Advances in Therapy|April 17, 2022
Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer TypesAracelis Z Torres, Nathan C Nussbaum, Christina M Parrinello, et al.
Advances in Therapy|April 17, 2022
Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate CancerMark D Danese, Jennifer Schenfeld, Jaime Shaw, et al.
Advances in Therapy|July 13, 2022
Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database AnalysisJashin J Wu, Marie-Hélène Lafeuille, Bruno Emond, et al.
Advances in Therapy|July 25, 2022
Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-to-Treat Relapsed/Refractory Multiple MyelomaJianming He, Heather Berringer, Bart Heeg, et al.
Advances in Therapy|April 28, 2022
Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims DatabasePhilip J Mease, Pamela Young, David Gruben, et al.
Advances in Therapy|February 28, 2022
Managing Cachexia in Head and Neck Cancer: a Systematic Scoping ReviewAntti A Mäkitie, Rasheed Omobolaji Alabi, Helena Orell, et al.
Advances in Therapy|April 16, 2022
Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled TrialsIrene E van der Horst-Bruinsma, Kurt de Vlam, Jessica A Walsh, et al.
Pageof 451